In light of the current political landscape, it has become more important than ever to focus on initiatives that can help us grow and heal as a society. One such initiative is the psychedelics medicine venture fund, which is the first fund of its kind to focus exclusively on supporting psychedelic businesses and research.
If you’re looking for psychedelic companies’ funding, get in touch with The Conscious Fund.
The psychedelic renaissance is well underway, with businesses and researchers popping up all over the world to explore the potential of these powerful medicines. Yet many of these enterprises are forced to operate in a legal grey area, working in countries where psychedelic substances are not explicitly illegal but also not recognized as having any medical benefits.
Most of the current psychedelic research takes place in the United States and Europe, where the substances are classified as Schedule I drugs, meaning they have a high potential for abuse and no accepted medical use. This limits researchers’ ability to study these substances and obtain funding. In addition, it creates legal hurdles for those seeking to use psychedelics in a clinical setting.
Despite these challenges, several countries take a more open-minded approach to psychedelics and their potential benefits. Let’s look at why we need psychedelic fund and how it can help:
1. Psychedelics can help alleviate anxiety and depression
Depression is a leading cause of disability worldwide, and it’s estimated that one in four people will experience a mental health problem in their lifetime. Anxiety disorders are the most common type of mental illness, affecting around 18% of the population.
Psychedelics have been found to be effective at treating both anxiety and depression. In a study on psilocybin (the active ingredient in magic mushrooms), 82% of participants reported a significant reduction in anxiety symptoms after just one session. A separate study on LSD showed that 83% of participants no longer met the criteria for anxiety disorder after a single dose.
2. Psychedelics can help people overcome addiction
Addiction is a chronic brain disease that causes compulsive drug seeking and use, despite harmful consequences. It is one of the most pressing public health issues worldwide, with around 19.7 million people suffering from addiction in the US alone. Psychedelic medicines can help to combat this issue.
3. There is a lot of bureaucratic red tape surrounding psychedelic research
Due to psychedelics’ current classification as Schedule I drugs, there is a lot of bureaucratic red tape surrounding psychedelic research. This means that it can be difficult to get funding for such research and obtain the necessary permissions from regulatory bodies.
4. A psychedelic medical venture fund could help address these issues
A psychedelic venture fund could help address some of the bureaucratic red tape surrounding psychedelic research. This would involve pooling money from private investors to finance research into the therapeutic potential of psychedelics. Such a venture fund could also be used to support initiatives that promote the safe and responsible use of psychedelics.
The psychedelics venture fund can provide money needed for psychedelic medicine start-ups. The potential benefits of psychedelics medicines are vast and far-reaching, and with the right investments, we can unlock their full potential. Contact us to learn more about how you can get involved in this crucial psychedelic medicine venture.